OMRF researchers found that, in laboratory mice, a particular white blood cell seems to play a key role in MS.
This award is tailored to support scientists and doctors early in their careers studying and treating sarcoidosis.
The SMILE trial will seek to identify individuals at high risk for developing lupus and treat them before they ever transition into the disease.
Morris Reichlin helped build OMRF into one of the world’s leading centers for lupus research and treatment.
The National Eye Institute will provide Bob Axtell with $2.8 million to study NMO.
These findings will help scientists understand how to better diagnose and treat the disease.